HFpEF: Updates and Unknowns by Dr. Ho (BIDMC)

Jennifer Ho, MD, describes major differences in pharmacotherapy used in patients with heart failure with preserved versus reduced ejection fraction. Dr. Ho reviews current practical approaches to diagnosing heart failure with preserved ejection fraction. She also outlines the current pathophysiologic paradigm of heart failure with preserved ejection fraction and limitations in current knowledge of disease mechanisms.